Is this you? Create Your Porfile

Natarajan Muthusamy

The Ohio State University Wexner Medical Center

Archive Network Publication Hotspot Collaboration

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Natarajan Muthusamy is active.

Explore More

Publication

Featured researches published by Natarajan Muthusamy.

Archive | 2015

TREATMENT OF CANCER USING ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR

John C. Byrd; Jason Dubovsky; Joseph A. Fraietta; Saar Gill; David J. Glass; Amy Johnson; Carl H. June; Saad S. Kenderian; Joan Mannick; Marcela Maus; Leon O. Murphy; Natarajan Muthusamy; David L. Porter; Marco Ruella; William R. Sellers; Mariusz A. Wasik

Archive | 2014

METHODS OF TREATING AND PREVENTING GRAFT VERSUS HOST DISEASE

John C. Byrd; Jason Dubovsky; Natarajan Muthusamy; Amy Johnson; David B. Miklos

Archive | 2016

Combination of chimeric antigen receptor therapy and amino pyrimidine derivatives

Daniela Angst; John C. Byrd; Jason Dubovsky; Joseph A. Fraietta; François Gessier; Saar Gill; Amy Johnson; Carl H. June; Marcela Maus; Natarajan Muthusamy; David L. Porter; Marco Ruella; Anna Vulpetti; Mariusz A. Wasik

Archive | 2017

terapia adjuvante com inibidor da quinase da família tec

Amy Johnson; Betty Y. Chang; Jason Dubovsky; John C. Byrd; Joseph J. Buggy; Natarajan Muthusamy; Richard B. Love; Tarak D. Mody

Archive | 2016

TRATAMIENTO DE CÁNCER UTILIZANDO RECEPTOR DE ANTÍGENO QUIMÉRICO ANTI-CD19

Leon O. Murphy; Natarajan Muthusamy; David L. Porter; Marco Ruella; William R. Sellers; Mariusz A. Wasik; Joseph A. Fraietta; Saar Gill; David Glass; Amy Johnson; Carl H. June; Saad S. Kenderian; Joan Mannick; Marcela Maus; Jennifer Brogdon; John C. Byrd; Jason Dubovsky

Archive | 2016

USO DE INHIBIDORES DE ACK PARA TRATAMIENTO Y PREVENCIÓN DE LA ENFERMEDAD DE INJERTO VERSUS HUÉSPED

John C. Byrd; Jason Dubovsky; Natarajan Muthusamy; Amy Johnson; David B. Miklos

Archive | 2016

Thérapie combinée par récepteur antigénique chimérique et dérivés d'amino pyrimidine

Archive | 2016

Title: Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1 selective pressure in T-lymphocytes Short Title: Ibrutinib is an immunomodulatory ITK inhibitor

Jason Dubovsky; Kyle A. Beckwith; Gayathri Natarajan; Samantha Jaglowski; Yiming Zhong; Joshua Hessler; Ta-Ming Liu; Betty Y. Chang; Karilyn Larkin; Matthew R. Stefanovski; Danielle L. Chappell; Frank Frissora; Lisa L. Smith; Kelly A. Smucker; Joseph M. Flynn; Leslie A. Andritsos; Kami Maddocks; Amy Lehman; Richard R. Furman; Jeff Porter Sharman; Anjali Mishra; Michael A. Caligiuri; Abhay R. Satoskar; Natarajan Muthusamy; Amy Johnson; John C. Byrd

Archive | 2015

Magnetic Tweezers-based 3D Microchannel Electroporation for Efficient Cell Manipulation and High-Throughput Gene Transfection

John C. Byrd; Zhaogang Yang; Wei-Ching Liao; Natarajan Muthusamy; L. James. Lee; Chi-Ling Chiang; Daniel Gallego-Perez; Marci Howdyshell; Wu Lu; Lingqian Chang

Archive | 2015

Traitement du cancer à l'aide du récepteur antigénique chimérique anti-cd19

Jennifer Brogdon; John C. Byrd; Jason Dubovsky; Joseph A. Fraietta; Saar Gill; David Glass; Amy Johnson; Carl H. June; Saad S. Kenderian; Joan Mannick; Marcela Maus; Leon O. Murphy; Natarajan Muthusamy; David L. Porter; Marco Ruella; William R. Sellers; Mariusz A. Wasik

Explore More